Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor β1 (TGF-β 1) as Predictors of Hepatocellular Carcinoma in HCV Related Liver Cirrhosis

被引:0
作者
El Shayeb, Ayman
Deghady, Akram [1 ,2 ]
Belal, Abdel-Aziz [3 ]
Eldin-Eldesoky, Salah [4 ]
机构
[1] Univ Alexandria, Fac Med, Dept Trop Med, Alexandria, Egypt
[2] Univ Alexandria, Fac Med, Dept Clin Pathol, Alexandria, Egypt
[3] Univ Alexandria, Fac Med, Clin Oncol & Nuclear Med Dept, Alexandria, Egypt
[4] Univ Alexandria, Fac Med, Dept Radiodiag, Alexandria, Egypt
来源
LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION | 2011年 / 8卷 / 04期
关键词
Chronic hepatitis C; hepatocellular carcinoma; liver cirrhosis; angiogenesis; HEPATITIS-C; CANCER-PATIENTS; BREAST-CANCER; SERUM-LEVELS; ANGIOGENESIS; DISEASES; PERMEABILITY; METASTASIS; EXPRESSION; RECEPTORS;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most serious complications of liver cirrhosis. Therefore, evaluation of biomarkers that predicts early the occurrence of HCC in patients with hepatitis C virus (HCV) induced liver cirrhosis is of great clinical value from the diagnostic and prognostic points of view. Aim: The aim of this work was to study serum levels of TGF-beta 1 and VEGF in cirrhotic HCV patients with and without HCC. Subjects and methods: This research was conducted on 30 patients with chronic HCV and liver cirrhosis (Group I), 30 patients with HCC on top of HCV induced liver cirrhosis (Group II) and 20 healthy controls.. Serum TGF-beta 1 and VEGF were measured by ELISA. Results: Mean VEGF and TGF-beta 1 levels were significantly higher in patients (Groups I and II) than controls. Furthermore, their values were significantly higher in HCC cases (Group II) than in those with liver cirrhosis (Group I). Significant positive correlations were noticed between each of TGF-beta 1 and VEGF and Child Pugh score (p < 0.05). Moreover, statistically significant positive correlations were observed between size of hepatic focal lesions and each of TGF-beta 1 and VEGF in group II patients (p < 0.05) Conclusion: Serum TGF-beta 1 and VEGF reflect well the degree of hepatic dysfunction. Their serial measurements might be of diagnostic and predictive value for occurrence of HCC in patients with chronic HCV induced liver cirrhosis. [Ayman El Shayeb, Akram Deghady, Abdel-Aziz Belal and Salah Eldin-Eldesoky Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor beta 1 (TGF-beta 1) as Predictors of Hepatocellular Carcinoma in HCV Related Liver Cirrhosis]. Life Science Journal. 2011;8(4):198-204] (ISSN:1097-8135). http://www.lifesciencesite.com.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 40 条
  • [1] Abdel- Haleem H, 2007, ARAB J GASTROENTEROL, V8, P84
  • [2] Abdelmoaty MA, 2009, INDIAN J CLIN BIOCHE, V24, P398, DOI 10.1007/s12291-009-0071-5
  • [3] Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
    Anan, K
    Morisaki, T
    Katano, M
    Ikubo, A
    Kitsuki, H
    Uchiyama, A
    Kuroki, S
    Tanaka, M
    Torisu, M
    [J]. SURGERY, 1996, 119 (03) : 333 - 339
  • [4] Bellamy WT, 1999, CANCER RES, V59, P728
  • [5] EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER
    BROWN, LF
    BERSE, B
    JACKMAN, RW
    TOGNAZZI, K
    GUIDI, AJ
    DVORAK, HF
    SENGER, DR
    CONNOLLY, JL
    SCHNITT, SJ
    [J]. HUMAN PATHOLOGY, 1995, 26 (01) : 86 - 91
  • [6] Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study
    Bruno, S
    Silini, E
    Crosignani, A
    Borzio, F
    Leandro, G
    Bono, F
    Asti, M
    Rossi, S
    Larghi, A
    Cerino, A
    Podda, M
    Mondelli, MU
    [J]. HEPATOLOGY, 1997, 25 (03) : 754 - 758
  • [7] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [8] Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery
    Chao, Y
    Li, CP
    Chau, GY
    Chen, CP
    King, KL
    Lui, WY
    Yen, SH
    Chang, FY
    Chan, WK
    Lee, SD
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 355 - 362
  • [9] Chun SK, 2007, J LEUKOCYTE BIOL, V81, P1
  • [10] Role of transforming growth factor beta in human cancer
    Elliott, RL
    Blobe, GC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 2078 - 2093